stars 1 stars 2 stars 3

Content Graph — Verification Intelligence for Your Complete Drug Lifecycle Small and mid-cap pharma lose capital, time, and programs to failures that could have been caught earlier. Non-viable candidates consume wet lab budgets. Unverified IND submissions attract Complete Response Letters. NDA narratives that cannot be defended against source data put years of investment at risk. The drag compounds at every stage. And the later it is caught, the more catastrophic the cost. Content Graph eliminates the drag. We deliver Big Pharma-grade verification across the complete drug development lifecycle, from first candidate to final NDA submission, at a price that fits an SMC pharma program budget. Our platform ingests outputs from any system: vHTS, LIMS, or AI, verifying candidate viability, IND accuracy, and NDA narrative integrity with forensic precision. We call this Data Integrity Protection™. Our founding team built Data Privacy, DLP, and Cloud Security infrastructure for regulated markets at Cisco. We are applying that same rigour in reverse, ensuring inaccurate data never infiltrates pharmaceutical intelligence. AI is advancing drug discovery. Verification ensures it accelerates in the right direction.

Website https://www.contentgraph.ai
Employees 2 (2 on RocketReach)
Founded 2025
Industry Technology, Information and Internet

Content Graph Questions

Kevin Holmes is the Founder and CEO of Content Graph.

2 people are employed at Content Graph.

Content Graph is based in London, England.

Top Content Graph Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users